The global disease control and prevention vaccine market is anticipated to grow at a considerable CAGR of 12.1% during the forecast period (2022-2028). All the major players in the global disease control and prevention vaccine market are involved in strategic alliances such as acquisitions, partnerships, and collaborations to launch new vaccines to stay competitive in the market. For instance, in February 2021, US FDA approved the COVID-19 vaccine of Johnson and Johnson Services Inc., as emergency use authorization for its single dose vaccine to prevent COVID-19 in individuals above 18 years.
Browse the full report description of “Global Disease Control and Prevention Vaccine Market Size, Share & Trends Analysis Report By Type (Live-Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Toxoid Vaccine, Others), and By Indication (Infectious Disease, Cancer, and Other Indication) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/disease-control-and-prevention-vaccine-market
Further, several vaccine manufacturers are working in partnership with WHO, UNICEF, and Global Alliance for Vaccine and Immunization (GAVI) to improve the vaccination program globally for reducing the number of patients suffering from diseases. Additionally, the Global Vaccine Action Plan was also endorsed by the 194 members of WHO in May 2012 with the main motive to prevent millions of deaths by 2020 through more equitable access to existing vaccines for the people in all communities. A part from this, in February 2022, WHO announced the first technology recipients for the mRNA vaccine that includes Egypt, Kenya, Nigeria, Senegal, South Africa, and Tunisia.
Market Coverage
• The market number available for – 2022-2028
• Base year- 2022
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Indication
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape - AstraZeneca, Astellas Pharma Inc., Blistex Inc., Church & Dwight Co., Inc., Serum Institute of India Pvt. Ltd., and many more
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Disease Control and Prevention Vaccine Market Report Segment
By Type
By Indication
Global Disease Control and Prevention Vaccine Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/disease-control-and-prevention-vaccine-market